期刊文献+

卵巢癌微血管密度与血管壁α-平滑肌肌动蛋白的表达及其临床意义 被引量:1

The microvessel density and expressions of α-smooth muscle actin in ovarian cancers and their clinical significance.
暂未订购
导出
摘要 目的 :研究卵巢癌微血管密度 (MVD)、血管壁α 平滑肌肌动蛋白 (α SMA)的表达并探讨其临床意义。方法 :通过免疫组化法 ,分别检测 2 1例卵巢良性肿瘤和 35例卵巢癌血管壁平滑肌特异性标志物α SMA和血管内皮细胞特异标志Ⅷ因子的表达 ,计算α SMA表达指数 (α SMA指数 )和MVD。结果 :卵巢癌血管α SMA中、强表达率为 31.4 % (11/ 35 ) ,明显低于良性肿瘤者的 6 1.9% (13/ 2 1)。卵巢癌α SMA指数平均为 0 .4 2± 0 .33,明显低于良性肿瘤者的 0 .72± 0 .38(P <0 .0 1)。卵巢癌的MVD平均为 2 8.2 7± 2 2 .34,良性肿瘤为 12 .5 3± 16 .5 8,两组差异有显著性 (P <0 .0 1)。α SMA表达及MVD均与临床分期及淋巴结转移有关。Ⅲ期和Ⅳ期卵巢癌的α SMA指数明显低于Ⅰ、Ⅱ期者 ;有淋巴结转移的α SMA指数明显低于无转移者。Ⅲ期和Ⅳ期卵巢癌的MVD明显高于Ⅰ、Ⅱ期者 ;有淋巴结转移的MVD明显高于无转移者。结论 :α SMA指数和MVD分别反映肿瘤新生血管的不同方面 ,α SMA指数反映新生血管的结构 ,MVD代表了新生血管的数量 。 Objective:To study the expressions of α smooth muscle actin(α SMA) and microvessel density(MVD) in ovarian cancer and their clinical significance.Methods:The expressions of α SMA and factor Ⅷ were measured by immunohistochemical assay in 21 cases of benign ovarian tumor and 35 cases of ovarian cancer.Results:The rate of moderate and strong expressions of α SMA in ovarian cancers was much lower than that in ovarian benign tumor 31.4% vs 61.9%.The average expression index of α SMA was significantly lower in ovarian cancer (0.42±0.33) than that of benign tumor (0.72±0.38) (P<0.01).The ovarian cancers showed much higher MVD(28.27±22.34), compared with that of benign tumors(12.53±16.58)(P<0.01).The expression index of α SMA and MVD were associated with lymphonode metastases and clinical stages of ovarian cancers.Conclusions:The expression index of α SMA may be used as substitute for the maturity of tumor vessels,The expression index of α SMA and MVD reflect different aspects of tumor angiogenesis,the expression index of α SMA reflects the situation of angiogenesis,while MVD is a substitute for the numbers of microvessels in tumors.
出处 《现代妇产科进展》 CSCD 2003年第5期373-375,共3页 Progress in Obstetrics and Gynecology
关键词 卵巢肿瘤 微血管密度 血管平滑肌 Α-平滑肌肌动蛋白 Ovarian neoplasms Microvessel density Blood vessel smooth muscle α Smooth muscle actin
  • 相关文献

参考文献8

  • 1张慧娟,Sanjiv Manek,Han Chen,Trivadi S.Ganesan.卵巢癌临床和生物学预测因子研究[J].现代妇产科进展,2002,11(4):251-254. 被引量:5
  • 2Kakolyris S, Fox SB, Kouralds, et al. Relationship of vascular maturation in breast cancer blool vessels to vascular density and metastasis, asseesed by expression of a novel basement membrane component ,LH39[J']. Brit J Cancer,2000,82:44-851.
  • 3Skinner SA, Frydman GM, O, Brien. Microvascular structure of benign and malignant tumors of the colon in humans [J]. Dig Dis Sci, 1995,40:373-384.
  • 4Warren B.The vascular morphology d tumors. In: Peterson H ed.Tumor Blood Circulation[J]. Boca Raton: CRC Press,1997:1-47.
  • 5Okamoto-Inoue M, Taniguchi S, Sadano H, et al. Alternation in expression of smooth muscle α-actin associated with trans-formation of rat 3Y1 cells[J] .J Cell Sci,1990,96:631-637.
  • 6Kobayashl H,Tsurchi N,Sugihara K,et al. Expression of α-smooth muscle actin in benign or malignant ovarian tumors [J]. Gynecol Oncol, 1993,48:308-313.
  • 7Fleischer AC, Rodgers WH, Kepple DM, et al. Color Doppler sonography of ovarian masses : a multiparameter analysis[J] .J Ultrasound Med, 1993,12:41-48.
  • 8Sakamoto N, Iwahana M, Tanaka NG, et al. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide. CDPGYIGSR-NH2[ J]. Cancer Res, 1991,51:903-906.

二级参考文献9

  • 1[1]Griffiths CT.Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma[J].Natl Cancer Inst Monogr,1975,42:101-104
  • 2[2]Hoskins WJ,McGuire WP,Brady MF,et al.The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma[J].Am J Obstet Gynecol,1994,170:974-80
  • 3[3]Maghaddam A,Zhang HT,Fan TPD,et al.Thymidine phosphorylase is angiogenic and promotes tumour growth[J].Proc Natl Acad Sci USA,1995,92:998-1002
  • 4[4]Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor(VEGF) in epithelial ovarian neoplasms:Correlation with clinical pathology and patient survival,and analysis of serum VEGF levels[J].Br J Pathol,1997,76:1221-1227
  • 5[5]Chen CHA,Cheng WF,Lee CHN,et al.Serum vascular endothelialgrowth factor in epithelial ovarian neoplasms:Correlation with patient survival[J].Gynecol Oncol,1999,74:235-240
  • 6[6]Hata K,Kamikawa T,Arao S,et al.Expression of the thymidine phosphorylase gene in epithelial ovarian cancer[J].Br J Cancer,1999,79:1848-1854
  • 7[7]Mesiano S,Ferrara N,Jaffe RB.Role of vascular endothelial growthfactor in ovarian cancer[J].Am J Pathol,1998,153:1249-1256
  • 8[8]Brustmann H,Riss P,Naude S.The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary:A quantitative histologic study[J].Gynecol Oncol,1997,67:20-26
  • 9[9]Abulafia O,Ruiz J,Holcomb K,et al.Angiogenesis in early invasiveand low malignat potential epithelial ovarian carcinoma[J].Obstet Gynecol,2000,95:548-552

共引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部